About 8 results found for searched term "Valproic acid" (0.121 seconds)
Cat.No. | Name | Target |
---|---|---|
M1876 | Valproic acid sodium | HDAC |
Sodium valproate | ||
Valproic acid (VPA) sodium is a histone deacetylase inhibitor which is reported to enhance central GABAergic neurotransmission and inhibit Na+ channels. Valproic acid (VPA) sodium is also an SSADH inhibitor. | ||
M9054 | Valproic acid | HDAC |
Erganyl; Stavzor; VPA | ||
Valproic acid (VPA) is an HDAC inhibitor with IC50 in the range of 0.5~2 mM. Valproic acid activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. | ||
M55461 | Valproic acid-d6 | HDAC |
Valproic acid-d6 | ||
M3427 | Divalproex Sodium | HDAC |
Divalproex Sodium consists of a compound of sodium valproate and valproic acid in a 1:1 molar relationship in an enteric coated form. | ||
M8204 | VAHA | Others |
Hydroxamic acid derivatives of valproic acid exhibit anticonvulsant activity with no teratogenic activity in mouse neural tube defect model. | ||
M8845 | Valpromide | Epoxide Hydrolase |
Valpromide (VPD) is a derivative of valproic acid (VPA) and is used as an antiepileptic drug. | ||
M8847 | Valnoctamide | GABA Receptor |
Valmethamide | ||
Valnoctamide, a GABA receptor activator, is a derivative of Valproic Acid, which has antiepileptic and anticonvulsant properties, and has shown stronger antiepileptic effects than Valproic Acid in a variety of animal models. | ||
M8960 | LY2334737 | DNA/RNA Synthesis |
LY2334737 is an orally available valproic acid ester of gemcitabine, a broad-spectrum antimetabolite with antineoplastic activity. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.